ADBiotech Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	2,449	638.53	3,015	1,179	1,195	2,438
Short-Term Investments	630	630	630	4,547	120	96
Trading Asset Securities	-	410.72	5,769	2,901	1,465	308.11
Cash & Short-Term Investments	3,079	1,679	9,414	8,628	2,781	2,842
Cash Growth	-7.32%	-82.16%	9.11%	210.28%	-2.17%	-
Accounts Receivable	2,508	2,930	1,596	1,873	3,497	1,733
Other Receivables	26.68	108.46	8.07	47.67	3.28	383.27
Receivables	2,535	3,039	1,604	2,321	3,500	2,117
Inventory	2,532	2,375	2,265	2,952	2,106	1,774
Prepaid Expenses	187.14	152.11	16.83	59.27	81.21	394.93
Other Current Assets	1,412	1,144	117.63	163.87	204.67	121.52
Total Current Assets	9,745	8,390	13,417	14,123	8,672	7,249
Property, Plant & Equipment	10,746	11,061	10,312	10,319	10,287	7,423
Long-Term Investments	1,975	1,923	1,585	6,491	1,878	3,938
Goodwill	-	704.45	1,126	-	-	-
Other Intangible Assets	35.24	898.15	1,029	2.4	5.11	11.94
Long-Term Accounts Receivable	-	-	-	-	0	0
Other Long-Term Assets	98.35	98.42	623.51	83	117.09	218.03
Total Assets	22,599	23,074	28,093	31,018	20,959	18,840
Accounts Payable	1,795	1,669	250.65	386.05	1,116	485.06
Accrued Expenses	214.09	585.44	212.78	250.12	341.01	401.94
Short-Term Debt	11,561	6,735	9,142	9,543	9,147	3,140
Current Portion of Long-Term Debt	781.72	653.96	399.08	166.56	773.78	55.45
Current Portion of Leases	40.76	60.72	89.38	21.09	19.92	24.95
Other Current Liabilities	1,097	3,797	1,174	1,426	1,229	1,387
Total Current Liabilities	15,489	13,501	11,268	11,793	12,626	5,495
Long-Term Debt	3,443	3,859	3,513	3,012	3,179	3,952
Long-Term Leases	365.97	413.32	466.24	28.1	49.18	65.3
Long-Term Deferred Tax Liabilities	303.68	483.29	205.32	-	-	-
Other Long-Term Liabilities	0	0	0	-	-	-
Total Liabilities	19,670	18,304	15,525	14,833	15,854	9,513
Common Stock	5,932	4,570	4,570	4,570	3,847	1,267
Additional Paid-In Capital	28,820	25,557	27,257	27,257	18,293	20,582
Retained Earnings	-29,840	-24,381	-16,431	-13,574	-16,270	-13,606
Comprehensive Income & Other	-824.54	-909.44	-2,004	-2,068	-763.03	1,084
Total Common Equity	4,088	4,837	13,393	16,185	5,106	9,327
Minority Interest	-1,777	-1,862	-2,545	-	-	-
Shareholders' Equity	2,929	4,771	12,569	16,185	5,106	9,327
Total Liabilities & Equity	22,599	23,074	28,093	31,018	20,959	18,840
Total Debt	16,193	11,722	13,610	12,771	13,168	7,238
Net Cash (Debt)	-13,114	-10,043	-4,196	-4,143	-10,388	-4,396
Net Cash Per Share	-1332.55	-1098.73	-459.08	-410.96	-1351.57	-879.51
Filing Date Shares Outstanding	11.86	9.14	9.14	9.14	7.69	5
Total Common Shares Outstanding	11.86	9.14	9.14	9.14	7.69	5
Working Capital	-5,745	-5,111	2,149	2,330	-3,954	1,754
Book Value Per Share	344.57	529.16	1465.20	1770.73	663.67	1866.18
Tangible Book Value	4,053	3,234	11,237	16,183	5,100	9,316
Tangible Book Value Per Share	341.60	353.83	1229.37	1770.47	663.00	1863.79
Land	5,321	5,321	3,868	3,868	641.06	641.06
Buildings	4,126	4,192	4,323	4,455	4,586	4,491
Machinery	808.59	967.43	1,411	1,729	2,201	318.5
Construction In Progress	-	-	14.4	117.47	2,784	1,864

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.